Medical Summary
Testosterone replacement therapy (TRT) is a clinically established treatment for male hypogonadism — the condition in which the testes fail to produce adequate testosterone, resulting in symptoms including fatigue, low libido, erectile dysfunction, mood disturbance, poor concentration, and loss of muscle mass. Diagnosis requires two fasting morning serum testosterone measurements below 12 nmol/L alongside consistent clinical symptoms, in line with British Society for Sexual Medicine (BSSM) guidance.[1] Treatment can be delivered through the NHS or via private clinics, and the cost varies substantially depending on the route taken, the formulation prescribed, and the level of monitoring included. On the NHS, TRT is available without patient-facing cost beyond standard prescription charges, but access is frequently restricted, inconsistent, or delayed. Private TRT in the UK typically costs between £80 and £250 per month when medication, consultations, and blood tests are factored together. This article provides a detailed, honest breakdown of TRT costs in the UK to help patients make informed decisions about their care pathway.[2]
The Real-World Cost of TRT in the UK: An Overview
Patients often ask us the same question in their first consultation: “How much does TRT actually cost?” The honest answer is that it depends heavily on the route you take and the formulation that suits you best. The NHS and private sectors operate with entirely different cost structures, and understanding both is essential before committing to treatment.
In the UK, testosterone is a prescription-only medicine (POM), meaning it cannot be purchased over the counter or without a valid prescription from a licensed prescriber. This regulatory reality shapes the entire cost landscape. Whether you go through your GP, an NHS endocrinologist, or a private men’s health clinic, you will always need ongoing medical oversight — and that oversight has a price, either to the taxpayer or to you directly.
The cost of TRT should never be assessed in isolation from the cost of not treating hypogonadism. Untreated low testosterone is associated with increased cardiovascular risk, reduced bone mineral density, type 2 diabetes, metabolic syndrome, and significantly diminished quality of life.[3] When we frame TRT cost in that clinical context, the investment takes on a very different character.
TRT on the NHS: What Is Available and What Does It Cost the Patient?
Technically, NHS TRT costs the patient very little. Testosterone prescriptions fall under the standard NHS prescription charge, which is currently £9.90 per item in England (2024–2025), with those in Scotland, Wales, and Northern Ireland often paying nothing at all. If you hold a prepayment certificate (PPC), the annual cost of prescriptions across all medications is capped at approximately £111.60, making ongoing TRT almost negligible in financial terms.[4]
The problem is not cost — it is access. In clinic we see many men who have spent months, sometimes years, navigating GP referrals, waiting lists for NHS endocrinology, and encountering scepticism about the legitimacy of their symptoms. NICE clinical guideline NG242 (2023) updated the framework for diagnosing and managing hypogonadism, but implementation across NHS trusts remains uneven.[2] Many GPs remain reluctant to initiate TRT independently and will refer to secondary care, where waiting times for a new endocrinology appointment can stretch to 12 to 18 months in some regions.
When NHS TRT is prescribed, the formulations available are often limited by local formulary restrictions. Nebido (testosterone undecanoate injection) and Sustanon 250 (testosterone propionate/phenylpropionate/isocaproate/decanoate blend) are the most commonly prescribed injectable options on the NHS. Testogel and Tostran (transdermal gels) are also available but can face restrictions. The prescribing decision may be dictated by cost to the NHS rather than clinical preference, which is an important limitation. For a thorough overview of NHS access, see our dedicated guide on TRT on the NHS.
Private TRT Cost in the UK: A Full Breakdown
Private TRT in the UK involves several distinct cost components: the initial consultation, diagnostic blood tests, the cost of the testosterone medication itself, follow-up consultations, and ongoing monitoring bloods. Each of these carries a fee, and the total monthly cost varies depending on the clinic and protocol chosen.
Initial consultation: A private men’s health consultation with a doctor experienced in TRT typically costs between £150 and £300. This should include a full clinical history, symptom assessment, and a review of any existing blood results. Some clinics include the cost of initial blood tests within a bundled package price.
Diagnostic blood tests: Before TRT is initiated, a full hormonal and haematological panel is required. This includes total testosterone (two fasting morning samples), LH, FSH, SHBG, prolactin, PSA (in men over 45), full blood count, and in some cases oestradiol and metabolic markers. A comprehensive private blood panel of this type typically costs between £80 and £200, depending on provider and number of markers included.[1]
Ongoing consultations and monitoring: BSSM and Endocrine Society guidelines both recommend regular monitoring at 3 months after initiation and then annually thereafter, including haematocrit, PSA, testosterone levels, and symptom review.[5] Private follow-up consultations typically cost between £75 and £150 per appointment. Monitoring blood tests are an additional £60 to £150 per panel, depending on frequency and scope.
Taken together, a realistic first-year cost for private TRT in the UK — including initiation, medication, two or three consultation appointments, and two blood test panels — sits between £800 and £1,800 depending on the clinic and formulation chosen. From year two onwards, when the cost profile stabilises to medication plus annual monitoring, patients typically spend £600 to £1,200 per year. This equates to roughly £50 to £100 per month at the lower end of the market, rising to £150 to £250 per month at premium London clinics.
Testosterone Blood Test Kit

If this test showed you have low testosterone, the Advanced Testosterone Blood Test will assess your suitability for TRT.
Testosterone Injection Price UK: Formulation-by-Formulation Costs
The cost of testosterone medication itself varies considerably depending on the formulation. Below is a clinical and financial breakdown of the most commonly used preparations available to UK patients privately.
Testosterone cypionate (e.g., Testosterone Cypionate 200 mg/mL): This is a widely used intramuscular or subcutaneous injectable ester with a half-life that supports weekly or twice-weekly dosing. It is not a UK-licensed product but is available as a specials-manufactured or imported preparation via private prescription. Cost per vial (10 mL, 200 mg/mL) typically ranges from £40 to £80, which at a weekly dose of 100–150 mg represents a monthly medication cost of approximately £16 to £35.
Testosterone enanthate: Similar pharmacokinetics to cypionate, with a slightly shorter half-life. Also available as a UK special or via importation. Costs are broadly comparable to cypionate, approximately £35 to £70 per 10 mL vial.
Sustanon 250 (testosterone blend): A UK-licensed product, making it more straightforwardly prescribable. It contains four testosterone esters designed to produce both rapid onset and sustained release. A single 1 mL ampoule (250 mg) costs approximately £3.50 to £5.00 via NHS prescription, but via private prescription, with pharmacy dispensing fees, patients typically pay £8 to £15 per ampoule. Most protocols use one ampoule every 10 to 14 days, giving a monthly medication cost of £15 to £30.
Nebido (testosterone undecanoate 1000 mg/4 mL): This is a long-acting depot injection administered every 10 to 14 weeks in the gluteal muscle, usually by a healthcare professional. The convenience of infrequent dosing is attractive, but testosterone levels can fluctuate significantly with this preparation, and the end-of-cycle trough is a common clinical complaint. The Nebido vial costs approximately £80 to £120 privately, plus the cost of an administration appointment if required. Per-month costs are therefore relatively low — approximately £25 to £40 in medication terms — but the absence of dose flexibility is a limitation.
Transdermal gels (Testogel 50 mg/5 g sachet, Tostran 2% gel pump): Gel preparations are popular for their ease of use and the avoidance of injections. Testogel sachets typically cost £2.50 to £4.50 per sachet privately, equating to a monthly medication cost of £75 to £135. Tostran pump dispensing can be slightly cheaper per dose. Gels avoid the peaks and troughs of injectable esters but carry a transference risk to partners and children if skin-to-skin contact occurs before the gel has dried.
Testosterone pellet implants: Subcutaneous pellet implantation is available at some private clinics in the UK, though it is less commonly used than in the United States. Pellets release testosterone steadily over three to six months. The procedure itself typically costs £400 to £700 per implantation appointment, making it one of the higher-cost options per intervention, though the lower frequency of treatment may appeal to some patients.
What Drives the Total Cost of Private TRT in the UK?
Patients often find it confusing that two private clinics can quote very different prices for what seems like the same treatment. Several factors genuinely affect the total cost, and understanding them helps you assess value rather than just price.
Prescriber qualifications and clinical model: TRT should only be prescribed and monitored by a clinician with relevant training — ideally a doctor with experience in endocrinology or men’s health. Clinics employing consultant-level doctors will charge more, but the quality of clinical oversight and the ability to manage complications or comorbidities is meaningfully higher.
Monitoring frequency and comprehensiveness: A responsible TRT clinic will not simply dispatch testosterone indefinitely without regular blood tests. Clinics that include regular haematocrit checks, PSA monitoring, oestradiol measurement, and symptom review in their pricing models are offering better value in clinical terms, even if their headline price is higher. Haematocrit elevation (polycythaemia) is one of the most clinically significant risks of TRT and must be tracked.[5]
Formulation availability and pharmacy sourcing: Not all private pharmacies stock every testosterone preparation, and the sourcing of unlicensed specials (such as testosterone cypionate) introduces additional complexity and variable cost. A clinic with established pharmacy partnerships can often secure more favourable medication pricing for patients than those sourcing ad hoc.
Geography: London clinic costs are consistently higher than those based in the Midlands, North of England, or Scotland. Remote and telephone consultation models have reduced this disparity somewhat, and many reputable clinics now operate entirely online with home blood testing kits, significantly lowering the effective cost for patients outside major cities.
Shared Care: Reducing the Long-Term Cost of Private TRT
A shared care arrangement — in which a private clinic initiates and stabilises TRT, and the patient’s NHS GP then takes over prescribing and monitoring — can significantly reduce long-term costs. Once testosterone levels are optimised and the patient is clinically stable, many GPs are willing to continue prescribing under shared care protocols, covering the medication cost through the NHS.
In practice, shared care uptake varies widely between GP practices. Some GPs are supportive, particularly if provided with a clear handover letter from a qualified private prescriber with full clinical documentation. Others decline, citing unfamiliarity with TRT or concerns about monitoring responsibilities. Patients should not assume shared care will be agreed upon automatically, but it is always worth requesting, as it can reduce ongoing private costs substantially once treatment is established.
Our detailed guide to TRT in the UK covers the shared care pathway in full, including how to approach your GP and what documentation to provide. For further background on what TRT actually involves clinically, see our overview of what TRT is.
Comparing TRT Cost to the Cost of Untreated Hypogonadism
In clinic we see men who have hesitated about TRT for months or years, principally because of cost concerns. When we explore their history more fully, many of them have spent considerable sums on supplements, energy drinks, private GP appointments for fatigue, or mental health support for mood symptoms that were, at root, hormonal. The cumulative cost of managing the symptoms of untreated hypogonadism often exceeds the direct cost of treatment itself.
Beyond personal expenditure, there is a broader economic argument. Research published in endocrinology literature consistently links low testosterone with increased rates of type 2 diabetes, cardiovascular events, osteoporotic fractures, and hospital admissions.[3] These conditions carry substantial NHS costs. Effective TRT that reduces these downstream risks represents genuine health economic value, even if that argument does not directly reduce what an individual patient pays at the pharmacy.
Quality of life must also feature in this calculation. Restored energy, improved mood, better sexual function, and maintained muscle mass are not trivial outcomes. For many of the patients we treat, the monthly cost of TRT is the most straightforwardly justifiable expenditure in their healthcare budget.
Testosterone Blood Test Kit

If this test showed you have low testosterone, the Advanced Testosterone Blood Test will assess your suitability for TRT.
References
[4] NHS England. Prescription charges and exemptions. NHS, 2024.